Table 5 PGx tests used in research and clinically and funding source for clinical use

ABCB1

5

1

.

.

1

ABCC2

3

.

.

.

.

ABCC3

2

.

.

.

.

ABCC4

2

.

.

.

.

CYP2B6

5

2

1

1

3

CYP2C cluster rs12777823

6

3

1

1

3

CYP2C19

10

13

10

2

7

CYP2C8

4

.

.

.

1

CYP2C9

7

8

4

1

6

CYP2D6

8

8

4

1

5

CYP3A4

7

2

1

1

3

CYP3A5

7

5

2

1

4

CYP4F2

5

3

2

1

4

DPYD

5

3

1

1

3

DRD1

2

.

.

.

.

DRD2

5

1

.

.

2

FAAH

3

.

.

.

.

G6PD

4

1

1

1

1

GRIN2A

2

.

.

.

.

HLA A 31 01

5

3

.

.

2

HLA B 15 02

5

3

.

.

2

HLA B 57 01

5

4

1

1

2

HLA B 58 01

5

3

.

.

2

HTR2A

6

1

1

1

3

HTR2C

5

1

1

1

3

IFNL3

4

3

1

.

2

ITPA

3

1

1

1

1

MTHFR

4

1

.

.

1

NUDT15

5

4

1

1

5

1-Oct

3

.

.

.

.

OPRM1

6

1

.

.

2

SLC6A4

6

1

.

.

2

SLCO1B1

8

7

2

1

6

SV2C

3

1

1

1

1

TPMT

5

7

6

1

4

UGT1A1

5

4

1

1

3

UGT1A9

4

1

1

1

1

UGT2B15

4

1

.

.

.

UGT2B7

4

1

.

.

1

VKORC1

7

6

4

1

6

Average per site

12.93

6.93

3.2

1.47

6.13

Range

2-10

0-13

0-10

0-2

0-7